Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
HCA Healthcare, Inc. reported fourth quarter ended December 31, 2022 results: revenue $15.497 billion, net income $2.081 billion, EPS $7.28 per diluted share. Guidance initiated.
- Period
- fourth quarter ended December 31, 2022
- Revenue
- $15.497 billion
- Net income
- $2.081 billion
- EPS
- $7.28 per diluted share
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
results for the fourth quarter ended December 31, 2022. Key fourth quarter metrics (all percentage changes compare 4Q 2022 to 4Q 2021 unless otherwise noted): ● Revenues totaled $15.497 billion ● Net income attributable to HCA Healthcare, Inc. totaled $2.081 billion, or $7.28 per diluted share ● Adjusted EBITDA totaled $3.179 billion ● Cash flows from operating
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
HCA Healthcare, Inc. reported year ended December 31, 2022 results: revenue $60.233 billion, net income $5.643 billion, EPS $19.15 per diluted share. Guidance initiated.
- Period
- year ended December 31, 2022
- Revenue
- $60.233 billion
- Net income
- $5.643 billion
- EPS
- $19.15 per diluted share
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
Revenues for the year ended December 31, 2022 totaled $60.233 billion, compared to $58.752 billion in the same period of 2021.
View on SEC.gov